AgroPages-Evogene prices its IPO in US-Agricultural news

Evogene (TASE: EVGN) recently announced the pricing of its initial public offering in the U.S. of 5 million ordinary shares at a price of US$14.75 per share. In connection with the offering, Evogene has granted the underwriters a 30-day option to purchase up to 750,000 additional ordinary shares at the same price per share.

As part of the offering, one of the company’s shareholders, Monsanto Company, has agreed to purchase 813,560 ordinary shares at the initial public offering price, amounting to approximately US$12 million.

The shares are expected to begin trading on the New York Stock Exchange under the symbol “EVGN” on November 21, 2013. The offering is expected to close on November 26, 2013.

Subscribe Email:		*
Name:
Mobile Number:

A Deep exploration into Regulatory Analysis, Join upcoming <2024 CROs & CRAOs Manual>Magazine

Join 2024 Formulation & Adjuvant Technology Magazine to Show Your Insights and Innovation SolutionsMagazine

BioEx 2024 successfully held: Biological innovation leading the way towards sustainable agricultureEvent

Evogene prices its IPO in US

Evogene Ltd.
Israel
Follow

More from AgroNewsChange

Magazine

Hot Topic More

NEWSLETTER